BioNTech SE (BNTX) — QMA analysis
Sector: Healthcare · Market cap: $26.2B · Price: $88.12 · Data as of 2026-10-24
BioNTech SE has a below-average composite score of 45/100, higher score than 55% of 22,734 tracked stocks. The highest-scoring layer is Analysts / transcripts; the lowest is Earnings quality.
What 12 data layers say about BNTX
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamental value (FVS) | 36/100 |
| Earnings quality (EQS) | 5/100 |
| Technical trend (TSS) | 49/100 |
| Relative strength (RS) | 59/100 |
| Momentum (USS) | 37/100 |
| Insider activity (IAS) | 10/100 |
| Off-exchange trading (FINRA) / large flows (WHS) | 37/100 |
| Institutional 13F (IFS) | 65/100 |
| Options flow (OFS) | 72/100 |
| News sentiment (NSS) | 61/100 |
| Analysts / transcripts (ATS) | 91/100 |
| Catalysts (XS) | 53/100 |
What does the QMA model currently show for BioNTech SE?
The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.
For BNTX the layers diverge — some score high (Analysts / transcripts), others low (Earnings quality). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.
BNTX insider & smart money activity
Over the recent period we record 0 reported insider purchases and 5 sales for BNTX: only reported sales, no purchases. A description of the data layer, not an instruction.
BNTX seasonality
BNTX is currently in its seasonal window October 1–28 with a hit rate of 75% and an average move of 3.1% (8 years of history).
Historical data does not guarantee future results.
BNTX dividend
BioNTech SE currently carries a dividend yield of 2.40% and has paid for 1 years in a row.
How BNTX compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for BNTX stock?
45/100 (grade D) as of 2026-10-24, fusing 12 data layers. An analytical score, not advice.
Are insiders buying BNTX stock?
Over the recent period, reported: purchases 0, sales 5 (sales $7.5M). Insider activity: only reported sales, no purchases — a description of reported data, not a trade instruction.
Where can I see live BNTX data?
Live BNTX data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.
Explore more — for free
The BNTX score is just the start. Keep going free in the QMA magazine — analysis, tools and learning with no payment up front.
Want the full BNTX analysis with all layers and live data? Open BNTX detail →
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]